A Randomized Controlled Study on the Impact of Early Urinary Catheter Removal on Postoperative Urinary Retention in Abdominal and Thoracic Surgery Patients with Thoracic Epidural Analgesia
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background: Thoracic epidural analgesia (TEA) is a key component of Enhanced Recovery After Surgery protocols for major abdominal and thoracic procedures. Despite its benefits for pain management, TEA has been associated with an increased risk of postoperative urinary retention (POUR). Consequently, it is common practice to maintain a urinary catheter (UC) for the duration of TEA. This study aimed to evaluate the impact of early UC removal in patients receiving TEA through a randomized controlled trial. Methods: In this randomized controlled trial approved by the Rostock University Medical Center Ethics Board (AZ A2018-0220), patients scheduled for elective major abdominal or thoracic surgery with anticipated TEA within 1 year were enrolled. Participants were randomized into two groups: the early removal group (ERG), where the UC was removed within 48 h post-surgery, and the standard group (SG), where the UC was retained until TEA discontinuation. POUR was defined as a residual urine volume of ≥400 mL measured by ultrasound, and catheter-associated urinary tract infections (CAUTIs) were assessed. Results: Of the 99 patients initially enrolled, 81 patients were available for analysis. In the ERG (n = 43), the UC was removed within 48 h, whereas in the SG (n = 38), the UC was maintained until TEA cessation. The incidence of POUR was similar between the groups, with 1 patient in each group (2.3% in ERG vs. 2.6% in SG, p = 1) requiring recatheterization. CAUTI developed in 4 patients (4.9%), all of whom were in the SG (10.5%), indicating a statistically significant association between the timing of UC removal and CAUTI incidence (p = 0.044). Conclusion: Our results suggest that early UC removal under TEA is safe and does not significantly increase the risk of POUR while reducing the incidence of CAUTIs. These findings support the feasibility of early UC removal in this patient population and may inform future guidelines on perioperative UC management in the context of TEA.
Source: Visceral Medicine
DOI: 10.1159/000548387
Authors: Ahmed Alwali, Clemens Schafmayer, Ernst Klar, Mark Philipp, Matthias Leuchter, Eberhard Grambow
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4414181646